That's better. The veil is lifted. Program going forward looks good - if a longer timeline than expected. Looks like a bit of reinvention of the wheel happening, but for the sake of definitive clinical data from a large-scale human trial the groundwork will be worth it. Perhaps a longer hold before significant action?
